Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peter Norman. (2016) Orphan drug approvals of 2015: Europe and the United States. Expert Opinion on Orphan Drugs 4:5, pages 491-500.
Read now
Read now
Articles from other publishers (4)
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Alaa Elwan, Mohammed A Dahab, Mohamed A Elkady, Elsayed GE Elsakka, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa & Ahmed M Metwaly. (2023) New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future Medicinal Chemistry.
Crossref
Crossref
Aleksandra Sochacka-Ćwikła, Marcin Mączyński & Andrzej Regiec. (2021) FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review. Cancers 14:1, pages 87.
Crossref
Crossref
Mohammed M. Alanazi, Hazem A. Mahdy, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Al-Mehizia, Sultan M. Alsubaie, Mohammed A. Dahab & Ibrahim H. Eissa. (2021) New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorganic Chemistry 112, pages 104949.
Crossref
Crossref
Liang Li, Wenpeng Zhang, Feng Lin, Xinqiang Lu, Wei Chen, Xingzhou Li, Xinbo Zhou, Ruibin Su, Lili Wang, Zhibing Zheng & Song Li. (2019) Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension. European Journal of Medicinal Chemistry 173, pages 107-116.
Crossref
Crossref